22nd Edition of Strategic Project & Portfolio Management for Pharma

This exclusive marcus evans conference will be a three-daylong physical/online event wherein the attendees can enjoy networking with one another and hear insights from Bayer, Merck, Janssen/Johnson, Roche, Novartis Institute for Biomedical Research, Leo-Pharma and many others on key industry topics such as:

•   Assess new opportunities in drug development

•   Innovate and invent new models for boosting performance and r&d productivity

•   Involve data analytics into PPM strategy from research to commercial phases

•   Align R&D and Portfolio Strategy and motivate your organisation to invest in long-term planning and capacity management

•   Balance scientific (data-driven) vs. commercial considerations (aspirational) in portfolio prioritization

•   Enhance project, program, and portfolio visibility to improve R&D Performance

•   Choose the right structure and methodology to support project planning

•    Accelerate investment in data sciences for better, more connected R&D insights

This conference is attended by heads, VPs, Senior Managers of Big Pharma, Biotech, Public Insitutions/Research Centers:

·   Project and/or Portfolio Management

·   Project / Strategic Planning

·   Project and/or Portfolio Analysis

·   Project and/or Portfolio Valuation

·    Business/ Corporate/ Strategic Development

·    Product Development

·    Pipeline Management/ Pipeline Portfolio

·    Investment/ Decision Support

·    Alliance management / Business Development

Special Discounts are available for Swiss Biotech Association Members! To take advantage of the discounts, email Mr Ayis Panayi at ayisp@marcusevanscy.com.